Michael Sabel

Researcher Next ID · RN-000256

Professor · Computer Science

Düsseldorf, Germany

Not currently recruitingFunding unknown

About

327 publications and 15,333 citations recorded on OpenAlex.

Computer Science

Glioma Diagnosis and Treatment

Brain Metastases and Treatment

Medical Imaging Techniques and Applications

Radiomics and Machine Learning in Medical Imaging

Meningioma and schwannoma management

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial
The Lancet · 2019 · 10.1016/s0140-6736(18)31791-4
MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial
Clinical Cancer Research · 2015 · 10.1158/1078-0432.ccr-14-2737
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial
The Lancet Oncology · 2012 · 10.1016/s1470-2045(12)70164-x
NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide
Journal of Clinical Oncology · 2009 · 10.1200/jco.2009.23.6497
Long-term survival with glioblastoma multiforme
Brain · 2007 · 10.1093/brain/awm204

No projects listed.